EUVIMEDEUVIMED entdecken
Kohortenstudie

Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands

L. van Tilburg, M. C. Spaander, M. J. Bruno, L. Heij, L. Oudijk, M. Doukas, A. D. Koch

Endoscopy · 01.04.2023 · 55 (S 02 S 02) · S110

DOI: 10.1055/s-0043-1765263 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Endoscopy, erschienen am 01.04.2023. Verfasst von L. van Tilburg und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess the risk of esophageal squamous cell carcinoma (ESCC) in patients with distinct grades of squamous dysplasia in a Western country.

Methods

This nationwide cohort study included all patients with esophageal squamous dysplasia, diagnosed between 1991 and 2020 in the Dutch nationwide histopathology registry (PALGA). Squamous dysplasia was divided in mild-to-moderate dysplasia (mild, low-grade, moderate dysplasia) and higher-grade dysplasia (high-grade, severe dysplasia, carcinoma in situ). The primary endpoint was the diagnosis of prevalent (≤6 months) and incident (>6 months after squamous dysplasia) ESCC, registered in PALGA and the Netherlands Cancer Registry.

Results

936 patients were included with esophageal squamous dysplasia (mild-to-moderate n=460, higher-grade dysplasia n=476). 57% of the patients with mild-to-moderate dysplasia received endoscopic re-assessment after 11 weeks (IQR 5-29), revealing mild-to-moderate dysplasia (20%), higher-grade dysplasia (11%), and ESCC (10%). ESCC was diagnosed in 80 (17.4%) patients with mild-to-moderate dysplasia (53 prevalent ESCC, 27 incident ESCC) and in 239 (50.0%) patients with higher-grade dysplasia (201 prevalent ESCC, 37 incident ESCC). After excluding prevalent ESCC, the progression incidence towards ESCC was 4.3 (95% CI 4.3-4.4) and 14.4 (95% CI 14.4-14.6) ESCC per 100 person-years in patients with mild-to-moderate and higher-grade dysplasia, respectively.

Conclusions

All patients with squamous dysplasia, including those with mild-to-moderate dysplasia, have a considerable risk of ESCC. Endoscopic surveillance of the esophageal mucosa is recommended for patients with mild-to-moderate dysplasia in Western countries. Publication History Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Tilburg, L. V., Spaander, M. C., Bruno, M. J., Heij, L., Oudijk, L., Doukas, M., & Koch, A. D. (2023). Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands. Endoscopy, 55(S 02 S 02), S110. https://doi.org/10.1055/s-0043-1765263

Vancouver

Tilburg LV, Spaander MC, Bruno MJ, Heij L, Oudijk L, Doukas M, et al. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands. Endoscopy. 2023;55(S 02 S 02):S110. doi:10.1055/s-0043-1765263

BibTeX
@article{Tilburg2023,
  author = {Tilburg, L. van and Spaander, M. C. and Bruno, M. J. and Heij, L. and Oudijk, L. and Doukas, M. and Koch, A. D.},
  title = {Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands},
  journal = {Endoscopy},
  year = {2023},
  volume = {55},
  number = {S 02 S 02},
  pages = {S110},
  doi = {10.1055/s-0043-1765263}
}
Kostenlos starten →